Literature DB >> 2920053

Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis.

J P Pelletier1, J Martel-Pelletier.   

Abstract

The in vivo effects of corticosteroids on osteoarthritic (OA) lesions were examined in 12 dogs in which the anterior cruciate ligament had been sectioned. Six were treated with oral prednisone and 6 were treated with intraarticular (IA) injections of triamcinolone hexacetonide (TH), at surgery and 4 weeks later. Twelve other operated dogs received no treatment. All dogs were killed 8 weeks postsurgery. Four of 15 normal control dogs received IA TH injections. Operated untreated dogs developed significant cartilage lesions on the femoral condyles and tibial plateaus with prominent osteophytes. Operated dogs treated orally or with IA injections had a significant reduction in osteophyte size. Cartilage erosions on femoral condyles were observed in 25% of the untreated dogs, 8% of the dogs receiving oral prednisone, and none of the dogs receiving IA TH. In both groups of treated dogs, the size of the tibial plateau lesions was significantly reduced compared with the operated untreated dogs. Histologically, corticosteroids significantly reduced the severity of OA structural changes of the cartilage on both medial and lateral femoral condyles and tibial plateaus in operated animals, with the exception of the lateral plateaus of those treated orally. In electron microscopy studies, we found no evidence of increased cell degeneration or death associated with steroids. IA corticosteroids had no deleterious effects on normal articular cartilage. These results indicate that glucocorticoids administered orally or intraarticularly are effective against the development of OA lesions in this model.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2920053     DOI: 10.1002/anr.1780320211

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  31 in total

Review 1.  Clinical assessment and significance of inflammation in knee osteoarthritis.

Authors:  V T Baddour; J D Bradley
Journal:  Curr Rheumatol Rep       Date:  1999-10       Impact factor: 4.592

Review 2.  Intra-articular therapy in osteoarthritis.

Authors:  I Uthman; J-P Raynauld; B Haraoui
Journal:  Postgrad Med J       Date:  2003-08       Impact factor: 2.401

Review 3.  Injections and return to play.

Authors:  Douglas P Dietzel; Eric C Hedlund
Journal:  Curr Pain Headache Rep       Date:  2005-02

Review 4.  The treatment of osteoarthritis.

Authors:  A C Jones; M Doherty
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 5.  Osteoarthritis: a review of old myths and current concepts.

Authors:  C J Alexander
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

Review 6.  Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs).

Authors:  H A Wynne; M Campbell
Journal:  Pharmacoeconomics       Date:  1993-02       Impact factor: 4.981

Review 7.  Corticosteroid injections and arthrocentesis.

Authors:  Paul Dooley; Rod Martin
Journal:  Can Fam Physician       Date:  2002-02       Impact factor: 3.275

8.  Efficacy comparisons of the intraarticular steroidal agents in the patients with knee osteoarthritis.

Authors:  Umut Yavuz; Sami Sökücü; Akif Albayrak; Kahraman Oztürk
Journal:  Rheumatol Int       Date:  2011-11-05       Impact factor: 2.631

Review 9.  Effect of various factors on articular cartilage and their implications on arthroscopic procedures: A review of literature.

Authors:  Sandeep Kohli; Varun Tandra; Abhinav Gulihar
Journal:  J Clin Orthop Trauma       Date:  2019-06-20

10.  Physiological levels of hydrocortisone maintain an optimal chondrocyte extracellular matrix metabolism.

Authors:  J Wang; D Elewaut; I Hoffman; E M Veys; G Verbruggen
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.